Treatment of myasthenia gravis

Current Neurology and Neuroscience Reports

Volumn 11, Issue 1, 2011, Pages 89-96

  Kumar, Vikas ^a   Kaminski, Henry J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine receptor; Acetylcholine receptor antibody; Azathioprine; Complement; Corticosteroid; Cyclosporine; Intravenous immunoglobulin; Muscle specific kinase; Myasthenia gravis; Mycophenolate mofetil; Ocular myasthenia; Plasma exchange; Thymectomy

Indexed keywords

AMBENONIUM; AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOSTIGMINE; PLACEBO; PREDNISONE; PYRIDOSTIGMINE; RITUXIMAB; SULFONAMIDE; TACROLIMUS; TIMESPAN; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ACUTE KIDNEY TUBULE NECROSIS; ALOPECIA; ANAPHYLAXIS; ANEMIA; ARTICLE; ASEPTIC MENINGITIS; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; BRADYCARDIA; BRONCHOSPASM; BULBAR PARALYSIS; CEREBROVASCULAR ACCIDENT; CHILL; CORTICOSTEROID INDUCED MYOPATHY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIARRHEA; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; FASCICULATION; FEBRILE NEUTROPENIA; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GRAFT REJECTION; GROWTH RETARDATION; HEART INFARCTION; HEMORRHAGIC CYSTITIS; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOMAGNESEMIA; INFECTION; KIDNEY FAILURE; LEUKEMIA; LEUKOPENIA; LIVER TOXICITY; LYMPHOMA; MIGRAINE; MUSCLE CRAMP; MUSCLE TWITCH; MUSCLE WEAKNESS; MYALGIA; MYASTHENIA GRAVIS; NAUSEA; NEOPLASM; NEPHROTOXICITY; NEUTROPENIA; ORBICULARIS OCULI MUSCLE; ORTHOSTATIC INTOLERANCE; PARESTHESIA; PATIENT CARE; PLASMAPHERESIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REMISSION; RESPIRATORY FAILURE; SIDE EFFECT; THROMBOCYTOPENIA; THROMBOSIS; THYMECTOMY; THYMOMA; TREMOR; VIDEO ASSISTED THORACOSCOPIC SURGERY; VOMITING; WEAKNESS;

ADRENAL CORTEX HORMONES; CHOLINESTERASE INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; MYASTHENIA GRAVIS;

EID: 79551559836     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0151-1     Document Type: Article

References (50)

1. A Vincent 2006 Immunology of disorders of neuromuscular transmission Acta Neurol Scand Suppl 183 1 7 1:STN:280:DC%2BD283jtVChug%3D%3D 10.1111/j.1600-0404.2006.00605.x 16637918
2. MI Leite S Jacob S Viegas, et al. 2008 IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis Brain 131 1940 1952 10.1093/brain/awn092 18515870 This article indicates that even patients who do not have antibodies directed against the AChR or MuSK likely have low levels of serum antibodies that bind the AChR. Some of these seronegative patients still may have antibodies directed at other proteins (Pubitemid 351957451)
3. JS Bae SM Go BJ Kim 2006 Clinical predictors of steroid-induced exacerbation in myasthenia gravis J Clin Neurosci 13 1006 1010 1:CAS:528:DC%2BD28Xht1CmtrnM 10.1016/j.jocn.2005.12.041 17074487 (Pubitemid 44750685)
4. J Palace J Newsom-Davis B Lecky 1998 A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group Neurology 50 1778 1783 1:CAS:528:DyaK1cXktFOisbw%3D 9633727
5. FM Howard Jr DD Duane EH Lambert JR Daube 1976 Alternate-day prednisone: preliminary report of a double-blind controlled study Ann N Y Acad Sci 274 596 607 10.1111/j.1749-6632.1976.tb47718.x 183591
6. A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group [no authors listed]. J Neurol Neurosurg Psychiatry 1993, 56:1157-1163.
7. VC Juel JM Massey 2005 Autoimmune myasthenia gravis: recommendations for treatment and immunologic modulation Curr Treat Options Neurol 7 3 14 10.1007/s11940-005-0001-7 15610702
8. MB Bromberg JJ Wald DA Forshew, et al. 1997 Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis J Neurol Sci 150 59 62 1:CAS:528:DyaK2sXjsVKmsbw%3D 10.1016/S0022- 510X(97)05370-7 9260858 (Pubitemid 27303794)
9. RS Tindall JT Phillips JA Rollins, et al. 1993 A clinical therapeutic trial of cyclosporine in myasthenia gravis Ann N Y Acad Sci 681 539 551 1:STN:280:DyaK3szmt12hug%3D%3D 10.1111/j.1749-6632.1993.tb22937.x 8357194
10. RS Tindall JA Rollins JT Phillips, et al. 1987 Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis N Engl J Med 316 719 724 1:STN:280:DyaL2s7ksVCltA%3D%3D 10.1056/NEJM198703193161205 3547126
11. E Ciafaloni NK Nikhar JM Massey DB Sanders 2000 Retrospective analysis of the use of cyclosporine in myasthenia gravis Neurology 55 448 450 1:STN:280:DC%2BD3cvgs1GitQ%3D%3D 10932288
12. AC Allison EM Eugui 2000 Mycophenolate mofetil and its mechanisms of action Immunopharmacology 47 85 118 1:CAS:528:DC%2BD3cXktlKkt7o%3D 10.1016/S0162-3109(00)00188-0 10878285 (Pubitemid 30394534)
13. E Ciafaloni JM Massey B Tucker-Lipscomb DB Sanders 2001 Mycophenolate mofetil for myasthenia gravis: an open-label pilot study Neurology 56 97 99 1:CAS:528:DC%2BD3MXnvF2hsA%3D%3D 11148243
14. MN Meriggioli J Rowin JG Richman S Leurgans 2003 Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study Ann N Y Acad Sci 998 494 499 1:CAS:528:DC%2BD3sXosFyntb8%3D 10.1196/annals.1254.064 14592919 (Pubitemid 37194203)
15. DB Sanders IK Hart R Mantegazza, et al. 2008 An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis Neurology 71 400 406 1:CAS:528:DC%2BD1cXptFSltL4%3D 10.1212/01.wnl.0000312374.95186.cc 18434638 This study was a well-performed, randomized, placebo-controlled trial that showed no benefit of mycophenolate and prednisone compared with prednisone alone. The study likely did not have long enough periods of study
16. Muscle Study Group 2008 A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis Neurology 71 394 399 10.1212/01.wnl.0000312373.67493.7f This study was a well-performed, randomized, placebo-controlled trial that showed no benefit of mycophenolate and prednisone compared with prednisone alone. The study likely did not have long enough periods of study
17. Y Furukawa H Yoshikawa K Iwasa M Yamada 2008 Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis J Neuroimmunol 195 108 115 1:CAS:528:DC%2BD1cXkvVOrsL4%3D 10.1016/j.jneuroim.2007. 12.008 18262659
18. JM Ponseti J Gamez J Azem, et al. 2007 Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study Curr Med Res Opin 23 1269 1278 1:CAS:528: DC%2BD2sXosF2ju7s%3D 10.1185/030079907X188080 17559724 (Pubitemid 46998436)
19. JM Ponseti J Azem JM Fort, et al. 2005 Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis Neurology 64 1641 1643 1:CAS:528:DC%2BD2MXjsVCjsbk%3D 10.1212/01.WNL.0000160392.32894.6D 15883336 (Pubitemid 40617711)
20. Y Nagane K Utsugisawa D Obara, et al. 2005 Efficacy of low-dose FK506 in the treatment of Myasthenia gravis-a randomized pilot study Eur Neurol 53 146 150 1:CAS:528:DC%2BD2MXlsVCqtL0%3D 10.1159/000085833 15900097 (Pubitemid 40864306)
21. RA Lewis RP Lisak 2003 "Rebooting" the immune system with cyclophosphamide: taking risks for a "cure"? Ann Neurol 53 7 9 10.1002/ana.10449 12509842 (Pubitemid 36083823)
22. DB Drachman RA Brodsky 2005 High-dose therapy for autoimmune neurologic diseases Curr Opin Oncol 17 83 88 10.1097/01.cco.0000152974.65477.35 15725909 (Pubitemid 40516274)
23. PT Lin BA Martin AB Weinacker YT So 2006 High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies Muscle Nerve 33 433 435 10.1002/mus.20411 16116645
24. LG De Feo J Schottlender NA Martelli NA Molfino 2002 Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis Muscle Nerve 26 31 36 10.1002/mus.10133 12115946 (Pubitemid 34734393)
25. WS Baek A Bashey GL Sheean 2007 Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis J Neurol Neurosurg Psychiatry 78 771 10.1136/jnnp.2006.093567 17575026 (Pubitemid 46998860)
26. B Hain K Jordan M Deschauer S Zierz 2006 Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab Muscle Nerve 33 575 580 10.1002/mus.20479 16323216
27. P Gajdos S Chevret B Clair, et al. 1997 Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group Ann Neurol 41 789 796 1:CAS:528:DyaK2sXktlyqsL4%3D 10.1002/ana.410410615 9189040 (Pubitemid 27249184)
28. J Ronager M Ravnborg I Hermansen S Vorstrup 2001 Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis Artif Organs 25 967 973 1:CAS:528:DC%2BD38XnsFahtg%3D%3D 10.1046/j.1525-1594.2001.06717.x 11843764 (Pubitemid 34107305)
29. RS Bedlack DB Sanders 2002 Steroid treatment for myasthenia gravis: steroids have an important role Muscle Nerve 25 117 121 10.1002/mus.1221 11754196 (Pubitemid 34019746)
30. P Gajdos C Tranchant B Clair, et al. 2005 Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial Arch Neurol 62 1689 1693 10.1001/archneur.62.11.1689 16286541 (Pubitemid 41626664)
31. L Zinman E Ng V Bril 2007 IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial Neurology 68 837 841 1:CAS:528: DC%2BD2sXisFyhu7s%3D 10.1212/01.wnl.0000256698.69121.45 17353471 The study is among the few controlled trials in MG. It demonstrates the efficacy of IVIG in the treatment of exacerbations of MG (Pubitemid 46568535)
32. AI Qureshi MA Choudhry MS Akbar, et al. 1999 Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis Neurology 52 629 632 1:STN:280:DyaK1M7kvVKlug%3D%3D 10025801
33. P Gajdos N Simon P de Rohan-Chabot, et al. 1983 Long-term effects of plasma exchange in myasthenia. Results of a randomized study] [in French Presse Med 12 939 942 1:STN:280:DyaL3s7psVymuw%3D%3D 6221247
34. Gajdos P, Chevret S, Toyka K: Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 2002, (4):CD002275.
35. GS Gronseth RJ Barohn 2000 Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 55 7 15 1:STN:280:DC%2BD3czovVOltQ%3D%3D 10891896
36. J Newsom-Davis G Cutter GI Wolfe, et al. 2008 Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone Ann N Y Acad Sci 1132 344 347 1:CAS:528:DC%2BD1cXoslSksLo%3D 10.1196/annals.1405.014 18567886 The article describes the first randomized, single-blinded, controlled trial of thymectomy for patients with MG. The study is about two-thirds completed at the time of publication of this review (Pubitemid 351841357)
37. MJ Magee MJ Mack 2009 Surgical approaches to the thymus in patients with myasthenia gravis Thorac Surg Clin 19 83 89 10.1016/j.thorsurg.2008.09.013 19288823
38. A Manlulu TW Lee I Wan, et al. 2005 Video-assisted thoracic surgery thymectomy for nonthymomatous myasthenia gravis Chest 128 3454 3460 10.1378/chest.128.5.3454 16304299 (Pubitemid 41698678)
39. M Benatar HJ Kaminski 2007 Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 68 2144 2149 10.1212/01.wnl.0000263481.14289.90 17460154 (Pubitemid 46912135)
40. N Sommer B Sigg A Melms, et al. 1997 Ocular myasthenia gravis: response to long-term immunosuppressive treatment J Neurol Neurosurg Psychiatry 62 156 162 1:STN:280:DyaK2s3gtVyrtQ%3D%3D 10.1136/jnnp.62.2.156 9048716
41. MJ Kupersmith G Ying 2005 Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment Br J Ophthalmol 89 1330 1334 1:STN:280:DC%2BD2Mvps1Oiug%3D%3D 10.1136/bjo.2004.063404 16170126 (Pubitemid 41638875)
42. J Mee M Paine E Byrne, et al. 2003 Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis J Neuroophthalmol 23 251 255 14663303
43. A McGrogan S Sneddon CS de Vries 2010 The incidence of myasthenia gravis: a systematic literature review Neuroepidemiology 34 171 183 10.1159/000279334 20130418
44. PI Andrews 2004 Autoimmune myasthenia gravis in childhood Semin Neurol 24 101 110 1:STN:280:DC%2BD2czmvFCgtQ%3D%3D 10.1055/s-2004-829591 15229797 (Pubitemid 38823784)
45. A Evoli 2010 Acquired myasthenia gravis in childhood Curr Opin Neurol 23 536 540 10.1097/WCO.0b013e32833c32af 20581680 This is an outstanding review of the challenges faced in caring for pediatric patients with MG. The author is an outstanding clinical scientist with a wealth of clinical experience
46. W Hoch J McConville S Helms, et al. 2001 Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies Nat Med 7 365 368 1:CAS:528:DC%2BD3MXhvVOktLg%3D 10.1038/85520 11231638 (Pubitemid 32224355)
47. M Pasnoor GI Wolfe S Nations, et al. 2010 Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience Muscle Nerve 41 370 374 10.1002/mus.21533 19882635
48. A Evoli MR Bianchi R Riso, et al. 2008 Response to therapy in myasthenia gravis with anti-MuSK antibodies Ann N Y Acad Sci 1132 76 83 1:CAS:528:DC%2BD1cXoslSlu7Y%3D 10.1196/annals.1405.012 18567856 (Pubitemid 351841355)
49. JT Guptill DB Sanders 2010 Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis Curr Opin Neurol 23 530 535 1:CAS:528:DC%2BC3cXhtV2gsbvL 10.1097/WCO.0b013e32833c0982 20613516
50. BM Conti-Fine M Milani HJ Kaminski 2006 Myasthenia gravis: past, present, and future J Clin Invest 116 2843 2854 1:CAS:528:DC%2BD28XhtFyrsLnE 10.1172/JCI29894 17080188 (Pubitemid 44684466)